Copyright
©The Author(s) 2017.
World J Hepatol. Nov 18, 2017; 9(32): 1227-1238
Published online Nov 18, 2017. doi: 10.4254/wjh.v9.i32.1227
Published online Nov 18, 2017. doi: 10.4254/wjh.v9.i32.1227
Patient | Gender | Age (yr) | Primary tumor site | Surgery |
1 | F | 74 | Rectum | Ex Rt |
2 | F | 57 | Rectum | Ex Rt |
3 | M | 76 | Cecum | Ex Rt |
4 | M | 43 | S/C | Ex Rt |
5 | M | 56 | Rectum | Ex Rt |
6 | M | 53 | Rectum | Ex Rt |
+ nonAnat S3 | ||||
7 | F | 47 | S/C | Ex Rt |
8 | F | 61 | Rectum | Ex Rt |
9 | F | 64 | S/C | Ex Rt |
10 | F | 63 | Rectum | Ex Rt |
+ nonAnat S3 |
- Citation: Iwao Y, Ojima H, Kobayashi T, Kishi Y, Nara S, Esaki M, Shimada K, Hiraoka N, Tanabe M, Kanai Y. Liver atrophy after percutaneous transhepatic portal embolization occurs in two histological phases: Hepatocellular atrophy followed by apoptosis. World J Hepatol 2017; 9(32): 1227-1238
- URL: https://www.wjgnet.com/1948-5182/full/v9/i32/1227.htm
- DOI: https://dx.doi.org/10.4254/wjh.v9.i32.1227